|

Rapamycin Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: Rapamune, sirolimus, Sirolimus, RAPA

Pipeline

Phase 1: 2Phase 2: 1Phase 2/3: 2

Top Sponsors

  • Umoja Biopharma1
  • The University of Texas Health Science Center at San Antonio1
  • Nanjing IASO Biotechnology Co., Ltd.1
  • Katarzyna Kotulska1
  • AgelessRx1

Indications

  • Cancer3
  • Geroscience1
  • Longevity1
  • GLP - 11
  • Alzheimer's Disease1

Other2 trials

Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Phase 2/3
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Phase 1

Duarte, California1 trial

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

City of Hope

Phase 1

Chicago, Illinois1 trial

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

AgelessRx

Phase 2/3

San Antonio, Texas1 trial

Rapamycin - Effects on Alzheimer's and Cognitive Health

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.